180 related articles for article (PubMed ID: 11212480)
1. The use of pentoxifylline in the treatment of type 2 reactional episodes in leprosy.
Nery JA; Perissé AR; Sales AM; Vieira LM; Souza RV; Sampaio EP; Sarno EN
Indian J Lepr; 2000; 72(4):457-67. PubMed ID: 11212480
[TBL] [Abstract][Full Text] [Related]
2. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
3. Does pentoxifylline find a place in the armementarium of leprologists in type II reaction?
Chatterjee M; Jaiswal AK
Indian J Lepr; 2002; 74(4):329-34. PubMed ID: 12624981
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN
Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline in the treatment of erythema nodosum leprosum.
De Carsalade GY; Achirafi A; Flageul B
J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
[TBL] [Abstract][Full Text] [Related]
6. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
7. The role of thalidomide in the management of erythema nodosum leprosum.
Walker SL; Waters MF; Lockwood DN
Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
[TBL] [Abstract][Full Text] [Related]
8. Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy.
Sales AM; de Matos HJ; Nery JA; Duppre NC; Sampaio EP; Sarno EN
Braz J Med Biol Res; 2007 Feb; 40(2):243-8. PubMed ID: 17273661
[TBL] [Abstract][Full Text] [Related]
9. Effect of cyclosporine A in erythema nodosum leprosum.
Uyemura K; Dixon JF; Wong L; Rea TH; Modlin RL
J Immunol; 1986 Dec; 137(11):3620-3. PubMed ID: 2946765
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
Front Immunol; 2018; 9():189. PubMed ID: 29479352
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic erythema nodosum leprosum with cyclosporine A produces clinical and immunohistologic remission.
Miller RA; Shen JY; Rea TH; Harnisch JP
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):441-9. PubMed ID: 3309088
[TBL] [Abstract][Full Text] [Related]
12. Reaction cases treated at the Regional Leprosy Training and Research Institute, Aska, Orissa: a retrospective analysis.
Santaram V; Porichha D
Indian J Lepr; 2004; 76(4):310-20. PubMed ID: 16119141
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL.
Moreira AL; Kaplan G; Villahermosa LG; Fajardo TJ; Abalos RM; Cellona RV; Balagon MV; Tan EV; Walsh GP
Int J Lepr Other Mycobact Dis; 1998 Mar; 66(1):61-5. PubMed ID: 9614845
[No Abstract] [Full Text] [Related]
14. Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients.
Chandorkar AG; Burte NP; Jadhav JH; Gade RK; Bulakh PM; Tayshete SN; Kale VM
Indian J Lepr; 1984; 56(2):264-8. PubMed ID: 6548496
[TBL] [Abstract][Full Text] [Related]
15. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL
Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum.
Villahermosa LG; Fajardo TT; Abalos RM; Balagon MV; Tan EV; Cellona RV; Palmer JP; Wittes J; Thomas SD; Kook KA; Walsh GP; Walsh DS
Am J Trop Med Hyg; 2005 May; 72(5):518-26. PubMed ID: 15891124
[TBL] [Abstract][Full Text] [Related]
17. Is pentoxifylline a viable alternative in the treatment of ENL?
Sarno EN; Nery JA; Garcia CC; Sampaio EP
Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):570-1. PubMed ID: 8642222
[No Abstract] [Full Text] [Related]
18. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.
Iyer A; van Eijk M; Silva E; Hatta M; Faber W; Aerts JM; Das PK
Clin Immunol; 2009 Jun; 131(3):501-9. PubMed ID: 19307157
[TBL] [Abstract][Full Text] [Related]
19. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
[TBL] [Abstract][Full Text] [Related]
20. Levamisole in cases of E.N.L.
Arora SK; Singh G; Sen PC
Indian J Lepr; 1985; 57(1):17-21. PubMed ID: 3897404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
